Page ---- SECTION 1. DEFINITIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1.1 Defined Terms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 SECTION 2....Funding Commitment • March 26th, 1998 • Firstcity Financial Corp • State commercial banks • New York
Kishore Mamillapalli 44445 Overland Ave. Culver City, CA 90230 October 2, 2011Funding Commitment • October 14th, 2011 • eCampusCash Inc. • Services-computer processing & data preparation
This letter agreement (the “Agreement”) confirms the commitment of the undersigned to arrange for financing for you (the “Company”) in a minimum amount of $200,000 over the twelve month period commencing on the date of this letter (the “Commitment Period.”)
Gurnet Point L.P. Cambridge, MA 02142Funding Commitment • October 26th, 2018 • Gurnet Merger Sub, Inc. • Pharmaceutical preparations • Delaware
Reference is made to the Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among Gurnet Holding Company, a Delaware corporation (“Parent”), Gurnet Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“Merger Sub”) and Corium International, Inc., a Delaware corporation (the “Company”), pursuant to which, among other things, Parent will acquire the Company by merging Merger Sub with and into the Company, on the terms and subject to the conditions set forth in the Merger Agreement. Capitalized terms herein used but not defined shall have the meanings ascribed to them in the Merger Agreement. This letter agreement is being delivered by the undersigned (the “Investor”) to the Company in connection with the execution of the Merger Agreement by Parent, Merger Sub and the Company.
FUNDING COMMITMENTFunding Commitment • April 7th, 2017 • Heat Biologics, Inc. • Pharmaceutical preparations
WHEREAS, pursuant to Section 6.13 of the Stock Purchase Agreement, dated March 7, 2017, as amended on March 29, 2017 (the “Purchase Agreement”), by and among Heat Biologics, Inc., a Delaware corporation (the “Purchaser”), Pelican Therapeutics, Inc., a Delaware corporation (the “Company”) and Josiah Hornblower, as representative of the Stockholders, Purchaser has requested that the Company provide a fully executed agreement with CPRIT with respect to the CPRIT Grant prior to the Closing; and
